Roche's AmpliChip CYP450 Test receives FDA clearance
First microarray-based diagnostic test for detection of genetic variations that can influence drug efficacy and adverse drug reactions
24-Feb-2005 -
Roche announced that its first microarray-based test, the AmpliChip CYP450 Test, has been cleared by the US Food and Drug Administration (FDA) for diagnostic use in the United States. This test, which is powered by Affymetrix microarray technology, analyses a patient's Cytochrome P450 2D6 and ...
Affymetrix
antidepressants
antipsychotics
+11